Management Guide for Hemolytic Uremic Syndrome

pediapp.online© 2026.

He Hemolytic Uremic Syndrome (HUS) It is a serious disease characterized by thrombotic microangiopathy. This means that small blood clots form in the smallest blood vessels in the body.

These clots can cause:

  • Hemolytic anemia: Red blood cells are destroyed as they pass through clogged vessels.
  • Thrombocytopenia: Platelets are consumed in the formation of clots, leading to a low count.
  • Acute Kidney Injury: Clots damage the small vessels in the kidneys, affecting their ability to filter blood.

Clinical Suspicion Criteria

HUS should be suspected in any child who presents the classic triad, especially after an episode of diarrhea (usually bloody).

Microangiopathic Hemolytic Anemia

(Paleness, jaundice, schistocytes)

Thrombocytopenia

(Petechiae, ecchymosis)

Acute Kidney Injury

(Oliguria, anuria, edema, HBP)

Initial Studies Panel

Study Expected Finding in SHU
Complete Blood Biometry Anemia (Hb < 10 g/dL), Thrombocytopenia (< 150,000/µL)
Peripheral Blood Smear Presence of schistocytes ("bitten" cells)
Blood Chemistry Elevation of Creatinine and BUN
Hemolysis Tests Elevated LDH, Decreased Haptoglobin, Elevated indirect bilirubin
Serum electrolytes Hyperkalemia, hyponatremia, metabolic acidosis
General Urine Examination Hematuria, proteinuria
Coproparasitoscopic and Shiga toxin in feces STEC-HUS confirmation

1. Fluid and Electrolyte Management

It is crucial to maintain euvolemia. Avoid water overload.

  • Initial solution: Saline 0.9%.
  • Aim: Maintain urine output > 1 ml/kg/hr.
  • Strict monitoring: Water balance, daily weight, vital signs.

2. Management of Arterial Hypertension (HTN)

1st Line Medication Presentation Dose
Amlodipine Tablets 5 mg 0.1 - 0.2 mg/kg/day, divided into 1-2 doses. Max 0.6 mg/kg/day.
Labetalol IV (HBP Crisis) Sol. Injectable 5 mg/ml Bolus: 0.2-1 mg/kg/dose. Infusion: 0.25-3 mg/kg/hour.

3. Re-evaluation and Monitoring Criteria

Re-evaluation must be continuous.

  • Every 4-6 hours: Vital signs, neurological status.
  • Every 12-24 hours: BH, kidney function, electrolytes.

Indications for Referring to the Pediatric Nephrologist

The reference must be IMMEDIATE before any of the following data:

  • Severe anuria or oliguria (>24h).
  • Volume overload refractory to diuretics.
  • Severe or difficult to control arterial hypertension.
  • Severe electrolyte alterations (Hyperkalemia > 6.5 mEq/L, severe acidosis).
  • Neurological compromise (seizures, lethargy, focusing).
  • Imminent need for dialysis.
  • Suspected atypical HUS (aHUS): no previous diarrhea, recurrences, family history.

Management by Nephrology

The nephrologist will evaluate the need for renal replacement therapies and specific treatments.

Therapeutic Option Main Indications
Peritoneal Dialysis / Hemodialysis Refractory anuria, fluid overload, symptomatic uremia, hyperkalemia or acidosis.

Management of Atypical HUS (aHUS)

aHUS requires a different approach, focusing on complement inhibition.

Medicine Presentation Dosage (example)
Eculizumab Sol. Injectable 300 mg/30 ml Dose by weight. Ex: 5-10 kg: 300 mg initial, then maintenance.

*Eculizumab is a highly specialized drug and its use is exclusive to pediatric nephrologist/hematologist.

Reference to Other Specialties

  • Hematology: Severe thrombocytopenia, need for plasmapheresis.
  • Gastroenterology: Severe colitis, rectal prolapse.
  • Pediatric Neurology: Any manifestation in the CNS.
  • Pediatric Cardiology: If there is evidence of cardiomyopathy or pericardial effusion.

What YES to do

  • Wash hands, fruits and vegetables well.
  • Thoroughly cook meat, especially ground meat.
  • Consult the doctor immediately if your child has bloody diarrhea.
  • Follow medical instructions regarding liquids and medications to the letter.
  • Monitor the amount of urine the child produces.
  • Ask all your questions to the health team.

What NOT to do

  • NEVER give antibiotics or medications to stop diarrhea (antimotility) without medical indication, as they may increase the risk or severity of HUS.
  • Do not consume unpasteurized milk or juices.
  • Do not self-medicate the child with anti-inflammatories (such as ibuprofen) if HUS is suspected, as they can further damage the kidney.
  • Do not ignore symptoms such as decreased urination, swelling or bruising.

1. What is the classic HUS triad?

2. What is the mainstay of treatment in typical HUS?

3. What finding is characteristic in the peripheral blood smear in HUS?

4. What drugs are contraindicated in the diarrheal phase due to the risk of precipitating HUS?

5. What is an IMMEDIATE indication for referral to pediatric nephrology?

  • Joseph C, et al. A clinical approach to the child with bloody diarrhea. Pediatr Rev. 2020;41(1):19-29.
  • Loirat C, Fakhouri F, Ariceta G, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15-39.
  • Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Buy Physiol. 2014;4(2):611-645.
  • Nelson Textbook of Pediatrics, 21st Edition. Kliegman RM, St. Geme JW, Blum NJ, et al. Elsevier, 2020.
  • UpToDate®. Overview of hemolytic uremic syndrome in children. (Consulted in 2024).